Early study reveals promising Alzheimer's disease treatment

July 18, 2008

A drug once approved as an antihistamine in Russia improved thinking processes and ability to function in patients with Alzheimer's disease in a study conducted there, said an expert at Baylor College of Medicine in Houston. The findings are published in the current issue of the journal The Lancet.

"More research is needed, but we are encouraged by the effect the drug Dimebon had on Alzheimer's patients" said Dr. Rachelle Doody, professor of neurology at BCM and lead author of the study.

In the study, the authors noted that Dimebon is the first drug for Alzheimer's disease that demonstrated continued improvement in patients over a 12 month period. Other approved drugs do not have this effect.

Half of the 183 patients in the Russian study received Dimebon; the other half were given a placebo or an inactive pill. Clinicians at the study sites then monitored the patients' progress over the next year on five different outcomes. All of those in the study had mild to moderate Alzheimer's disease.

"What we saw in the clinical trial is that people on the medication continued to improve over time," Doody said. "Those on placebo continued to decline."

Researchers believe the medication works by stabilizing mitochondria, the cellular components that produce energy, and possibly by inhibiting brain cell death. Researchers evaluated patients' thinking and memory ability, overall function, psychiatric and behavioral symptoms, and ability to perform daily activities.

"Usually at this point in a drug's development, we are happy to see improvement in one of the outcome measures," Doody said. "We saw improvement in all five."

Some participants complained of occasional dry mouth, but no one opted out of the study because of the side effects.

"As we continue research, we hope to replicate these results," Doody said. "My belief is that this drug will turn out to be useful for Alzheimer's disease, regardless of the stage of the disease."

Doody said this is only the first study looking into the effects of Dimebon on Alzheimer's disease. She also noted that it involved only a relatively small population from one specific region of the world. The ongoing Phase 3 study will include several international locations including the United States.

Source: Baylor College of Medicine

4.7 /5 (12 votes)  

Rank 4.7 /5 (12 votes)
Relevant PhysicsForums posts

More news stories

Researchers make breakthrough in stem cell research

(Medical Xpress) -- University of Queensland scientists have developed a world-first method for producing adult stem cells that will substantially impact patients who have a range of serious diseases.

Medicine & Health / Research

created 50 minutes ago | popularity 5 / 5 (2) | comments 0 | with audio podcast

Georgia Tech develops software for the rapid analysis of foodborne pathogens

2011 brought two of the deadliest bacterial outbreaks the world has seen during the last 25 years. The two epidemics accounted for more than 4,200 cases of infectious disease and 80 deaths. Software developed at Georgia Tech ...

Medicine & Health / Diseases

created 42 minutes ago | popularity not rated yet | comments 0

Can Viagra treat childhood lymphatic disorder?

(Medical Xpress) -- A surprising potential therapy for severe, hard-to-treat malformations of the lymphatic system is now being studied at the Stanford School of Medicine and Lucile Packard Children’s Hospital: researchers ...

Medicine & Health / Diseases

created 17 minutes ago | popularity not rated yet | comments 0 | with audio podcast

Don't ignore kids' snores

(Medical Xpress) -- Your ears aren’t playing tricks on you – that is the sound of snoring you hear from the bedroom of your preschooler. Snoring is common in children, but in some cases it can be a symptom of a ...

Medicine & Health / Diseases

created 7 minutes ago | popularity not rated yet | comments 0

WHO calls for stepped-up fight against leprosy

The World Health Organization called Monday for greater efforts to fight leprosy, warning the disfiguring disease was defying efforts to wipe it out across many countries in the Asia-Pacific region.

Medicine & Health / Diseases

created 13 minutes ago | popularity not rated yet | comments 0


New molecule has potential to help treat genetic diseases and HIV

(PhysOrg.com) -- Chemists at The University of Texas at Austin have created a molecule that's so good at tangling itself inside the double helix of a DNA sequence that it can stay there for up to 16 days before ...

With climate change, today's '100-year floods' may happen every three to 20 years: research

Last August, Hurricane Irene spun through the Caribbean and parts of the eastern United States, leaving widespread wreckage in its wake. The Category 3 storm whipped up water levels, generating storm surges ...

Researchers make better heat sensor based on butterfly wings

(PhysOrg.com) -- Scientists have long known that butterfly wings produce their iridescent colors by bouncing light around and between tiny ridges in structures made of chitin. More recently they’ve discovered ...

Social psychologist: Lust makes you smarter and evidence that seven deadly sins are good for you

(Medical Xpress) -- Good news for lovers on Valentine’s Day - the seven deadly sins, including Lust, are good for you. University of Melbourne social psychologist Dr Simon Laham uses modern research to make a compelling ...

The joy of cheques

An electronic cheque which eliminates the need for costly processing by banks but preserves the simplicity and ease of a traditional cheque book has been designed by a team of academics in the UK.

Research shows promise in converting camelina oil into jet fuel

(PhysOrg.com) -- Researchers at Montana State University-Northern have developed a process to convert camelina oil to jet fuel and other high-value chemicals. MSU has applied for a U.S. patent and research is ongoing.